slotkoers
Dhaka S.E.
00:00:00 25-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
116,1
BDT
|
-0,43%
|
|
-1,36%
|
-20,59%
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
33.864
|
28.065
|
79.096
|
68.969
|
65.222
|
51.794
|
-
|
-
|
Bedrijfswaarde
1 |
33.864
|
37.934
|
86.052
|
80.148
|
65.222
|
57.787
|
52.677
|
47.306
|
K/w-verhouding
|
11,2
x
|
7,98
x
|
15,4
x
|
13,5
x
|
14,1
x
|
9,44
x
|
7,69
x
|
6,11
x
|
Dividendrendement
|
1,8%
|
2,17%
|
1,97%
|
2,26%
|
-
|
3,45%
|
4,31%
|
5,17%
|
Marktkapitalisatie/omzet
|
1,48
x
|
1,1
x
|
2,68
x
|
1,99
x
|
1,66
x
|
1,16
x
|
1,03
x
|
0,9
x
|
Bedrijfswaarde/omzet
|
1,48
x
|
1,48
x
|
2,92
x
|
2,31
x
|
1,66
x
|
1,3
x
|
1,04
x
|
0,83
x
|
Bedrijfswaarde/EBITDA
|
5,64
x
|
5,64
x
|
11,1
x
|
9,38
x
|
-
|
5,91
x
|
4,7
x
|
3,63
x
|
Bedrijfswaarde/FCF
|
-23,2
x
|
11,5
x
|
24,6
x
|
34,9
x
|
-
|
12,1
x
|
8,52
x
|
6,3
x
|
FCF Yield
|
-4,3%
|
8,7%
|
4,06%
|
2,87%
|
-
|
8,26%
|
11,7%
|
15,9%
|
Price to Book
|
1,14
x
|
0,86
x
|
2,14
x
|
1,7
x
|
-
|
1,09
x
|
1
x
|
0,9
x
|
Aantal aandelen (in duizenden)
|
446.112
|
446.112
|
446.112
|
446.112
|
446.112
|
446.112
|
-
|
-
|
Referentieprijs
2 |
75,91
|
62,91
|
177,3
|
154,6
|
146,2
|
116,1
|
116,1
|
116,1
|
Datum van publicatie
|
11/11/19
|
11/11/20
|
2/11/21
|
8/11/22
|
1/11/23
|
-
|
-
|
-
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
22.817
|
25.612
|
29.494
|
34.669
|
39.267
|
44.551
|
50.494
|
57.302
|
EBITDA
1 |
6.009
|
6.723
|
7.765
|
8.543
|
-
|
9.785
|
11.203
|
13.018
|
Bedrijfsresultaat (EBIT)
1 |
5.066
|
5.609
|
6.651
|
6.901
|
7.216
|
7.905
|
8.962
|
10.251
|
Operationele Marge
|
22,2%
|
21,9%
|
22,55%
|
19,91%
|
18,38%
|
17,74%
|
17,75%
|
17,89%
|
Resultaat voor belastingen (EBT)
1 |
3.946
|
4.653
|
6.378
|
6.687
|
6.069
|
6.914
|
8.125
|
9.691
|
Nettowinst (verlies)
1 |
3.033
|
3.515
|
5.141
|
5.123
|
4.612
|
5.132
|
6.000
|
7.168
|
Nettomarge
|
13,29%
|
13,72%
|
17,43%
|
14,78%
|
11,74%
|
11,52%
|
11,88%
|
12,51%
|
WPA
2 |
6,800
|
7,882
|
11,49
|
11,48
|
10,34
|
12,30
|
15,10
|
19,00
|
Free Cash Flow
1 |
-1.457
|
3.299
|
3.498
|
2.299
|
-
|
4.776
|
6.184
|
7.514
|
FCF-marge
|
-6,38%
|
12,88%
|
11,86%
|
6,63%
|
-
|
10,72%
|
12,25%
|
13,11%
|
Kasstroomconversie (ebitda)
|
-
|
49,07%
|
45,04%
|
26,91%
|
-
|
48,81%
|
55,2%
|
57,72%
|
Kasstroomconversie (nettowinst)
|
-
|
93,86%
|
68,04%
|
44,87%
|
-
|
93,06%
|
103,07%
|
104,83%
|
Dividend per aandeel
2 |
1,364
|
1,364
|
3,500
|
3,500
|
-
|
4,000
|
5,000
|
6,000
|
Datum van publicatie
|
11/11/19
|
11/11/20
|
2/11/21
|
8/11/22
|
1/11/23
|
-
|
-
|
-
|
Fiscaal tijdperk: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
9.869
|
6.956
|
11.179
|
-
|
5.993
|
884
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4.488
|
Hefboom (schuld/ebitda)
|
-
|
1,468
x
|
0,8958
x
|
1,309
x
|
-
|
0,6125
x
|
0,0789
x
|
-
|
Free Cash Flow
1 |
-1.457
|
3.299
|
3.498
|
2.299
|
-
|
4.776
|
6.184
|
7.515
|
ROE (netto-inkomsten/eigen vermogen)
|
10,6%
|
11,2%
|
14,8%
|
13,2%
|
-
|
11,6%
|
13%
|
14,7%
|
ROA (netto-inkomsten/totale activa)
|
6,53%
|
7,08%
|
10%
|
-
|
-
|
7,6%
|
8,9%
|
10,9%
|
Totale activa
1 |
46.476
|
49.642
|
51.182
|
-
|
-
|
67.526
|
67.416
|
65.766
|
Nettoactief per aandeel
2 |
66,30
|
72,80
|
83,00
|
91,00
|
-
|
106,0
|
116,0
|
129,0
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2.244
|
2.526
|
2.915
|
-
|
2.090
|
1.000
|
1.000
|
Capex/omzet
|
-
|
8,76%
|
8,56%
|
8,41%
|
-
|
4,69%
|
1,98%
|
1,75%
|
Datum van publicatie
|
11/11/19
|
11/11/20
|
2/11/21
|
8/11/22
|
1/11/23
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
116,1
BDT Gemiddelde koersdoel
153,5
BDT Spread / Gemiddelde doel +32,21% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -20,59% | 472 mln. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|